ATAGI gives green light to Novavax Covid – 19 vaccine

Image Source: © Alphaspirit |


  • The Novavax Covid-19 vaccine has been approved by the ATAGI for people aged 18 and above.
  • The vaccine would be available by February. 
  • The recommended course for the vaccine will be two doses.

After getting provisional approval by the Therapeutic Goods Administration (TGA) last week, Novavax has finally been given the green light by Australian Technical Advisory Group on Immunisation (ATAGI).

Australian Health Minister - Greg Hunt has confirmed that Novavax will be rolled out from 21 February 2022.

Also known as Nuvaxovid, the spike protein-based vaccine - Novavax can be used for COVID-19 vaccination in people aged 18 or above.

As per the ATAGI, recommended schedule for administration is two doses, with a minimum duration of 3 weeks.

The regulator hasn’t given any specific precaution related to Novavax and said it could be administered to pregnant and breastfeeding women. 

Image source – © Erdosain |

While there are no safety or immunogenicity data available for these groups with the Novavax vaccine, there are no safety concerns related to its use in pregnancy, as Novavax isn’t a live vaccine.

People who were earlier infected with SARS-CoV-2 can also get administered with Novavax. 

Also, people with severe immunocompromise can receive Novavax. However, it isn’t recommended to be used as a booster.

Related read - COVID-19 continues to batter Australia: Will Omicron wave peak soon?

The vaccine can be further administered as a part of a heterologous primary schedule for people who have received other doses and co-administered with other vaccines on the requirement.

However, TGA hasn’t approved Novavax to be used as a COVID-19 booster vaccine. 

Based on phase 2 and 3 trials with over 45,000 participants, Novavax has been demonstrated as a highly effective vaccine preventing symptomatic COVID-19 in adults. ATGAI is yet to provide an update on the Novavax after further data evaluation to check the efficacy and safety of the vaccine. 

The Australian Federal Government has ordered nearly 51 million vaccine doses, and some of them will be given away under Australia’s vaccine donation program.



The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.